Skip to main navigation
close search window
Cingulate Therapeutics Logo Cingulate Therapeutics Logo
CING | Nasdaq Listed
Header Menu
  • Company
    • About Cingulate®
    • Senior Management
    • Board of Directors
    • Scientific Advisors
  • Pipeline
    • Pipeline Overview
    • ADHD Patient Experience
      • Patient Experience
      • Treatments
    • Cingulate® Technology
    • Publications
    • CTx-1301: ADHD
    • CTx-1302: ADHD
    • CTX-2103: Anxiety
  • Partners
  • Investors
    • Webcasts & Presentations
    • Corporate Governance
    • Financials & Filings
      • SEC Filings
    • Analyst Coverage
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
    • IR Resources
      • Investor FAQs
      • Email Alerts
      • Contact IR
  • Careers
  • Press Releases
  • Cingulate In the News
  • Contact us
Header Social TwitterLinkedInFacebookYoutube
Header Menu
  • Company
    • About Cingulate®
    • Senior Management
    • Board of Directors
    • Scientific Advisors
  • Pipeline
    • Pipeline Overview
    • ADHD Patient Experience
      • Patient Experience
      • Treatments
    • Cingulate® Technology
    • Publications
    • CTx-1301: ADHD
    • CTx-1302: ADHD
    • CTX-2103: Anxiety
  • Partners
  • Investors
    • Webcasts & Presentations
    • Corporate Governance
    • Financials & Filings
      • SEC Filings
    • Analyst Coverage
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
    • IR Resources
      • Investor FAQs
      • Email Alerts
      • Contact IR
  • Careers
  • Press Releases
  • Cingulate In the News
  • Contact us
back to top
close search window
Search:
search submit button
 

Event Details

15 May 2023 at 11:00 AM EDT May 2023 Benzinga All Access

Click here for webcast
CTx®_4C
TwitterLinkedInFacebookYoutube

Contact us

1901 W 47th Place
Kansas City 66205

 

info@cingulate.com
913-942-2300

© Cingulate® |  PRIVACY POLICY